Lawrence Samkoff is a Neurology physician affiliated with University of Rochester Medical Center. OpenAlex indexes 50 publications with 851 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1425 Portland Ave
Rochester, NY 14621
Telephone
585-922-4371Registry record last updated 5 Jul 2023.
Clinical trials
- Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
Sponsor: Vaccinex Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
52.1%Potassium Channel Blocker12.1%Dalfampridine Er100%Part D≥24 patientsGabapentinoids12%Gabapentin72%Pregabalin28%Part D<11 patients+ 9 more classes in this area
Cancer & immunology
23.8%Other immunostimulants16.1%Glatiramer Acetate60%Copaxone40%Part D<11 patientsCD20-directed Cytolytic Antibody3.3%Kesimpta Pen100%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
20%gamma-Aminobutyric Acid-ergic Agonist18.7%Baclofen100%Part D≥46 patientsCentral alpha-2 Adrenergic Agonist1.3%Tizanidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors
Current Treatment Options in Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Louis Constine, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Edward Messing, MD
University of Rochester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”